EXPD
43
-4
WHR
65
-5
MMM
35
-5
ECL
55
-2
WMB
68
2
RHI
57
-6
K
51
-3
TMO
42
-6
TEL
60
-8
ROST
57
-3
MDLZ
32
-4
JWN
48
-2
VNO
46
-13
CVS
41
-4
LEN
50
-2
UPS
48
2
XEL
67
2
O
17
-13
ADM
28
3
IR
63
-3
EXPD
43
-4
WHR
65
-5
MMM
35
-5
ECL
55
-2
WMB
68
2
RHI
57
-6
K
51
-3
TMO
42
-6
TEL
60
-8
ROST
57
-3
MDLZ
32
-4
JWN
48
-2
VNO
46
-13
CVS
41
-4
LEN
50
-2
UPS
48
2
XEL
67
2
O
17
-13
ADM
28
3
IR
63
-3
Financhill
Back

BioLife Solutions 10K Form

Sell
26

BLFS
BioLife Solutions

Last Price:
21.02
Seasonality Move:
12.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-10 10Q BLFS/BioLife Solutions Quarterly
2023-11-09 10Q BLFS/BioLife Solutions Quarterly
2023-08-09 10Q BLFS/BioLife Solutions Quarterly
2023-05-11 10Q BLFS/BioLife Solutions Quarterly
2022-11-09 10Q BLFS/BioLife Solutions Quarterly
2022-08-09 10Q BLFS/BioLife Solutions Quarterly

Receive BLFS News And Ratings

See the #1 stock for the next 7 days that we like better than BLFS

BLFS Financial Statistics

Sales & Book Value

Annual Sales: $143.27M
Cash Flow: $3.69M
Price / Cash Flow: 169.66
Annual Sales: $7.04
Price / Book: 3

Profitability

EPS (TTM): -1.01000
Net Income (TTM): $-46.03M
Gross Margin: $46.75M
Return on Equity: -13.95%
Return on Assets: -11.61%

BioLife Solutions Earnings Forecast

Key BioLife Solutions Financial Ratios

  • The Gross Profit Margin over the past 35 years for BLFS is 32.63%.
  • The Selling, General & Administrative Expenses for BLFS have been equal to 56.05% of Gross Profit Margin.
  • The Research & Development expenses have been 13.12% of Revenue.
  • The Interest Expense is -0.49% of Operating Income.
  • The Net Earning history of BLFS is -46.36% of Total Revenues.
  • Per Share Earnings over the last 35 years have been positive in 15 years.

BioLife Solutions Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BLFS
CUSIP: 09062W
Website: biolifesolutions.com

Debt

Debt-to-Equity Ratio: 0.06
Current Ratio: 2.78
Quick Ratio: 1.62

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 764.36

BLFS Technical Analysis vs Fundamental Analysis

Sell
26
BioLife Solutions (BLFS) is a Sell

Is BioLife Solutions a Buy or a Sell?

  • BioLife Solutions stock is rated a Sell
    The current BioLife Solutions [BLFS] share price is $21.02. The Score for BLFS is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.